0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Protein-coupled magnetic beads > VEGF165 > MBS-K036

Human VEGF165-coupled Magnetic Beads

Materials Provided
ItemsSize (2mg)Size(5mg X 2)
Particle size2 μm2 μm
Physical appearancePowder mixturePowder mixture
Amount of Coupled Protein>1121 pmol (25 μg) VEGF165/mg Beads>1121 pmol (25μg) VEGF165/mg Beads
Binding Capacity>137 pmol (20μg) Anti-VEGF antibody/mg beads>137 pmol (20 μg) Anti-VEGF antibody/mg beads
FormulationPBS, pH7.4, with 10% TrehalosePBS, pH7.4, with 10% Trehalose
Reconstitution2 mL ultrapure water (1 mg beads/mL)5 mL ultrapure water (1 mg beads/mL)
  • Background
    The Human VEGF165-coupled Magnetic Beads is produced by coupling biotinylated human VEGF165 protein to streptavidin-conjugated magnetic beads. The pre-coupled beads are ready to use for capturing anti-VEGF165 antibody or VEGFR2/KDR protein from your sample with high specificity. The uniform size and large surface-to-volume ratio of the beads ensure highly efficent immunocapture in a simple, fast and convenient workflow with high reproducibilty of data.
  • Application
    This product is intended for immunocapture, biopanning and flow cytometry. This is a non-sterile product.
  • Reconstitution
    See Certificate of Analysis (CoA) for detailed instruction.
  • Storage

    Upon receipt, please store the Beads at -20℃. The shelf life is 1 year at -20 ℃.

    Please avoid more than 3 freeze-thaw cycles. Immediate use after reconstitution is highly recommended.

  • Assay Principles
    The magnetic beads technology makes use of the easy and efficient collection of beads in magnetic field to facilitate antibody purification in a simple workflow of “bind-wash-elute”. In contrast to common separation techniques, this method does not require columns or centrifugation, and is therefore ideal in high-throughput applications.

    Antibody Purification:

    1. Resuspend the lyophilized beads by adding the buffer of choice.

    2. Add analyte to the suspension, mix and incubate to enable specific binding of the beads and the target protein.

    3. Magnetize beads, remove supernatant, and wash unbound protein fractions to capture target protein-bound beads.

    4. Wash, magnetize the beads and collect purified target protein for use in downstream applications.

Typical Data
Human VEGF165-coupled Magnetic BeadsHuman VEGF165-coupled Magnetic Beads (Cat. No. MBS-K036) ELISA bioactivity

Immobilized 31.6 μg VEGF165 protein/1mg beads can bind Anti-VEGF Antibody with an EC50 of 0.7726 μg/mL (QC tested).

Human VEGF165-coupled Magnetic BeadsHuman VEGF165-coupled Magnetic Beads (Cat. No. MBS-K036) ELISA bioactivity

Accelerated stability test. After placing the lyophilized beads at 37℃ for 7 days, binding activity between the Human VEGF165-coupled Magnetic Beads (Cat.No. MBS-K036) and Bevacizumab showed little deviation from the unaccelerated sample (%RSD<10%). Data were measured on day 0, 3, 7 respectively.

Human VEGF165-coupled Magnetic BeadsHuman VEGF165-coupled Magnetic Beads (Cat. No. MBS-K036) ELISA bioactivity

Freeze-thaw stability test. After different freeze-thaw cycles, binding activity between the Human VEGF165-coupled Magnetic Beads (Cat.No. MBS-K036) and Bevacizumab showed little deviation from the unfree-thaw sample (%RSD<10%). Three freeze-thaw cycles were performed.

Comments (0)

Order Details

Price(USD) : $800.00

Price(USD) : $2500.00

Promotion & Exhibitions



Drug Development Status

  • Number of Launched Drugs:20 Details
  • Number of Drugs in Clinical Trials:64 Details
  • Latest Research Phase:Approved

Datasheet & Documentation

Request for DMF
DMF (Drug Master File)

Contact Us

+1  800-810-0816 (US)
+86 400-682-2521 (AP)

Questions & Comments

This web search service is supported by Google Inc.

totop